This study investigates the association between post-reperfusion (neohepatic) ALBI scores and post-LT renal outcomes in living-donor LT (LDLT) recipients.
Acute kidney injury (AKI) after liver transplantation (LT) significantly affects patient and graft outcomes. The Albumin-Bilirubin (ALBI) score, an objective and sensitive index of liver function, has potential applicability in predicting outcomes following LT. This study investigates the association between post-reperfusion (neohepatic) ALBI scores and post-LT renal outcomes in living-donor LT (LDLT) recipients.
Study Type
OBSERVATIONAL
Enrollment
3,422
Asan Medical Center
Seoul, Song-pa Gu, South Korea
acute kidney injury
determined by change in sCr according to the Kidney Disease: Improving Global Outcomes (KDIGO) definition (increase in sCr of ≥26.5 mmol litre-1 within 48h or ≥1.5 times baseline within 7 days after surgery
Time frame: within 7 days after surgery
chronic kidney injury
when renal function assessed by calculating estimated serum glomerular filtration using the abbreviated modification of diet in renal disease equation was \<60 mL/min/1.73 m2 for 3 months or more, irrespective of cause
Time frame: within 1 year after surgery
graft failure
graft failure
Time frame: the graft failure at overall period (calculated from the date of surgery to the last follow-up) from the date of surgery (up to 10 years)]
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.